Finance

IDEA AG is a biopharmaceutical company focusing on targeted therapeutics in pain management and provides development services in the field of dermatology. IDEA AG is privately owned and financed by a strong and experienced group of institutional international biotech investors:

  • 3i Group
  • Celtic Pharma
  • Gilde Investment Management, The Netherlands
  • HealthCap
  • Life Sciences Partners (LSP), The Netherlands
  • Quest for Growth, Belgium
  • TechnoStart, Germany

To date, IDEA AG has raised equity capital in four financing rounds.

Given the fact that IDEA's technology is based on new insights rather than new chemical entities, the Company is able to maximise product opportunities and to minimise risk (e.g. risks related to regulatory approval). This allows relatively inexpensive and fast product development at a pace that is rarely seen in the biotechnology industry.

For further information please contact IDEA's Investor Relations:

  • e-mail:
    investorrelations@idea-ag.de
  • Mailing address:
    IDEA AG
    Investor Relations
    P.O. Box 40 09 21
    D-80709 Munich (Germany)
    Telephone: +49 89 324633-0
    Facsimile: +49 89 3241684
go to top | /\ back /\ Impressum © IDEA AG